FDA Issues Temporary Guidance for Compounding Neonatal Parenteral Nutrition Drug Products

The U.S. Food and Drug Administration (FDA) has released new guidance on the compounding of certain starter parenteral nutrition drug products for neonates. This guidance, published for immediate implementation, addresses the expected market exit of a predominant source of these critical products in the United States.